Share this post on:

Product Name :
Methotrexate

Search keywords :
(±)-Methotrexate

drugId :
null

Target Vo:
Dihydrofolate reductase

Target Vo Short Name :
DHFR

Moa_Name:
Dihydrofolate reductase inhibitors

First Approval Country :

First Approval Date Filter:
1953

Origin Company_Name :
Antares Pharma

Active Company_Name :
Antares Pharma

Active Indication_Name:
Lymphoma, Non-Hodgkin

In Active Indication_Name:
Lymphoma, Extranodal NK-T-Cell

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Occludin Antibody site
Palivizumab Technical Information
Phospho-CDC37 (Ser13) Antibody (YA219): Phospho-CDC37 (Ser13) Antibody (YA219) is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to Hsp90 co-chaperone Cdc37 (CDC37). It can be used for WB,IP assays in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related